Concepedia

Jonathan D. Herman

JD

Statistics

Publications

12

Citations

525

H-Index

11

Active since

1987

Affiliations

Harvard University(Current)

Ragon Institute of MGH, MIT and Harvard

Brigham and Women's Hospital

Massachusetts Institute of Technology

Center for Systems Biology

Jonathan D. Herman is an author at Harvard University specializing in medicine, biochemistry, and pharmacology.

ORCID

Top concepts

Publications per year

1987–2024

12

Publications

12

The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs

Jonathan D. Herman, Lauren R. Pepper, Joseph F. Cortese et al. · Science Translational Medicine · 2015 · 108 citations · Full text

Sodium stibogluconate (pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid β-oxidation in leishmania mexicana amastigotes

Jonathan D. Herman, James V. Gallalee, James M. Best · Biochemical Pharmacology · 1987 · 103 citations

, , +6

Torins are potent antimalarials that block replenishment of <i>Plasmodium</i> liver stage parasitophorous vacuole membrane proteins

Kirsten K. Hanson, Ana S. Ressurreição, Kathrin Buchholz et al. · Proceedings of the National Academy of Sciences · 2013 · 83 citations · Full text

, , +15

Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response

Jonathan D. Herman, Chuangqi Wang, Carolin Loos et al. · Nature Communications · 2021 · 49 citations · Full text

A genomic and evolutionary approach reveals non-genetic drug resistance in malaria

Jonathan D. Herman, Daniel P. Rice, Ulf Ribacke et al. · Genome biology · 2014 · 48 citations · Full text

1–5 of 12